Form 4 for IMA ImageneBio, Inc.

Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0001803794-26-000001 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-03-18	2026-03-16	IMA	Yarema Kristin	CEO, Dir	A - Grant	$0.00	+85.4K	85.4K	New	$0
D	2026-03-18	2026-03-16	IMA	Yarema Kristin	CEO, Dir	A - Grant	$0.00	+128.1K	128.1K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-16	A	A	85,400	$0.00	85,400	D	—	—	(F1) Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on March 15, 2027, and the balance will vest in successive equal quarterly installments on each of the next 12 Standard Quarterly Dates thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")) through each such vesting date. The "Standard Quarterly Dates" are each of March 15, June 15, September 15 and December 15.
2	Derivative	Employee Stock Option (right to buy)	2026-03-16	A	A	128,100	$0.00	128,100	D	$6.20 · — to 2036-03-16	128,100 Common Stock	(F2) This option vests over four years, with 25% of the shares subject to this option vesting on March 15, 2027, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2025 Plan) through each such vesting date.